Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.26 EUR | +1.35% | -0.44% | -23.13% |
Apr. 26 | Nexstim plc Receives Order for A New NBS System 5 from an Existing Customer Hospital in Germany | CI |
Apr. 22 | Nexstim Wins Order for Navigated Brain Stimulation System in US | MT |
Sales 2024 * | 8.6M 9.2M | Sales 2025 * | 11.2M 11.98M | Capitalization | 15.29M 16.35M |
---|---|---|---|---|---|
Net income 2024 * | - 0 | Net income 2025 * | - 0 | EV / Sales 2024 * | 1.96 x |
Net Debt 2024 * | 1.6M 1.71M | Net Debt 2025 * | 900K 962K | EV / Sales 2025 * | 1.45 x |
P/E ratio 2024 * |
-28.3
x | P/E ratio 2025 * |
22.6
x | Employees | 37 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 51.18% |
Latest transcript on Nexstim Plc
1 day | +1.35% | ||
1 week | -0.44% | ||
Current month | -2.59% | ||
1 month | +3.20% | ||
3 months | -8.13% | ||
6 months | +3.67% | ||
Current year | -23.13% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 47 | 14-08-17 | |
Director of Finance/CFO | 38 | 14-04-30 | |
Gustaf Järnefelt
CTO | Chief Tech/Sci/R&D Officer | 63 | 07-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 62 | 19-11-10 | |
Director/Board Member | 53 | 21-04-30 | |
Director/Board Member | 65 | 21-04-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 2.26 | +1.35% | 8,989 |
24-04-25 | 2.23 | -3.04% | 11,321 |
24-04-24 | 2.3 | -1.29% | 3,568 |
24-04-23 | 2.33 | +0.43% | 6,906 |
24-04-22 | 2.32 | +2.20% | 30,400 |
Delayed Quote Nasdaq Helsinki, April 26, 2024 at 11:02 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.13% | 16.32M | |
+8.07% | 219B | |
+6.59% | 183B | |
+11.26% | 133B | |
+26.57% | 108B | |
+0.65% | 63.06B | |
+13.35% | 52.02B | |
-0.62% | 48.2B | |
-0.93% | 40.37B | |
+11.54% | 39.35B |
- Stock Market
- Equities
- NXTMH Stock